An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine. The company said the newly approved formulation ...

The global outbreak of mpox in 2022–23 affected more than 100 countries and grabbed the attention of the scientific community. Research on mpox has intensified since.

This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing global outbreak.

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.

A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...

China on Thursday reported an outbreak of monkeypox virus, specifically the Ib sub-branch, with four associated cases. The ...

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US government to add to vaccine reserves.

The freeze-dried formulation provides flexibility with regard to storage and shelf life. The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox ...

Marketed as Jynneos in the US, the vaccine currently exists in a liquid-frozen formulation. These products require a temperature-controlled supply chain that keeps them frozen between production ...